NCT06915688View on ClinicalTrials.gov

A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations

NANot yet recruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

July 28, 2025

Study Completion Date

July 31, 2025

Conditions
COPD
Interventions
DRUG

Doxycycline

Doxycycline will be given to COPD group 1

DRUG

Levofloxacin

Levofloxacin given to copd patients

Trial Locations (1)

Unknown

General hospital, Lahore

All Listed Sponsors
lead

Amina Aslam

OTHER_GOV

NCT06915688 - A Study Comparing Doxycycline and Levofloxacin for Treating COPD Exacerbations | Biotech Hunter | Biotech Hunter